ATWOOD & PALMER INC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
ATWOOD & PALMER INC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$23,036
-9.7%
1,8110.0%0.00%0.0%
Q2 2023$25,499
-8.9%
1,8110.0%0.00%
-33.3%
Q1 2023$27,980
-5.7%
1,8110.0%0.00%0.0%
Q4 2022$29,682
-12.7%
1,8110.0%0.00%0.0%
Q3 2022$34,000
+41.7%
1,8110.0%0.00%
+50.0%
Q2 2022$24,000
+41.2%
1,8110.0%0.00%
+100.0%
Q1 2022$17,000
-5.6%
1,8110.0%0.00%
-50.0%
Q4 2021$18,000
-71.0%
1,8110.0%0.00%
-66.7%
Q3 2021$62,000
-6.1%
1,8110.0%0.01%0.0%
Q2 2021$66,000
-18.5%
1,8110.0%0.01%
-25.0%
Q1 2021$81,000
-21.4%
1,8110.0%0.01%
-27.3%
Q4 2020$103,000
+10.8%
1,8110.0%0.01%
-8.3%
Q3 2020$93,000
-13.9%
1,8110.0%0.01%
-20.0%
Q2 2020$108,000
+44.0%
1,8110.0%0.02%
+25.0%
Q1 2020$75,000
-33.6%
1,8110.0%0.01%
-20.0%
Q4 2019$113,000
+85.2%
1,8110.0%0.02%
+87.5%
Q3 2019$61,000
+48.8%
1,8110.0%0.01%
+33.3%
Q2 2019$41,000
-2.4%
1,8110.0%0.01%0.0%
Q1 2019$42,000
+10.5%
1,8110.0%0.01%0.0%
Q4 2018$38,000
-45.7%
1,8110.0%0.01%
-33.3%
Q3 2018$70,000
-1.4%
1,8110.0%0.01%
-10.0%
Q2 2018$71,0001,8110.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,086,723$85,910,00025.70%
SV Health Investors, LLC 449,951$18,525,00015.54%
Redmile Group, LLC 5,116,263$210,637,0005.90%
Eversept Partners, LP 414,081$17,047,7154.24%
Sunesis Advisors, LLC 96,299$3,965,0003.99%
Avoro Capital Advisors LLC 2,000,000$82,340,0002.78%
Opaleye Management Inc. 222,000$9,140,0002.42%
SECTORAL ASSET MANAGEMENT INC 204,059$8,401,0001.61%
Artal Group S.A. 800,000$32,936,0001.39%
Atika Capital Management LLC 141,000$5,805,0001.11%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders